$
2. 04
-0.03
-1.4493%
$
23.51M Market Cap
- P/E Ratio
- Div Yield
11,955 Volume
- Eps
$ 2.07
Previous Close Investors:
Want to track SER and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Serina Therapeutics Inc. (SER) Statistics
Valuation metrics
Market Cap 23.51M
Enterprise value 1.07M
Trailing P/E (ttm) -1.05
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 172.5
Price/Book (mrq) 1.41
Enterprise Value/Revenue 8.22
Enterprise Value/EBITDA -0.05
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 43.7K
Average volume (90 days) 64.8K
Price summary
52-Week low 1.22
52-Week high 7.92
Beta -
50-Day moving average 1.95
200-Day moving average 2.06
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 28:1,000
Last split Date 15 Mar 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -163.59%
Operating margin -188.03%
Operational effectiveness
Return on assets -0.78%
Return on equity -4.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.77
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.04
Total debt (mrq) -
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 4.18%
Book value per share (mrq) 1.46
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
